149 related articles for article (PubMed ID: 38099989)
1. Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects.
Kim HC; Yang E; Lee S; Oh J; Lee M; Lee C; Ha KS; Lee WS; Jang IJ; Yu KS
Invest New Drugs; 2024 Feb; 42(1):80-88. PubMed ID: 38099989
[TBL] [Abstract][Full Text] [Related]
2. Effect of food on the pharmacokinetic characteristics of a single oral dose of LCB01-0371, a novel oxazolidinone antibiotic.
Sunwoo J; Kim YK; Choi Y; Yu KS; Nam H; Cho YL; Yoon S; Chung JY
Drug Des Devel Ther; 2018; 12():1707-1714. PubMed ID: 29928114
[TBL] [Abstract][Full Text] [Related]
3. Effect of Food on the Pharmacokinetics of Senaparib (IMP4297) in Healthy Chinese Subjects.
Meng X; Lin X; Jiang R; Lu Y; Zeng L; Cao M; Zhang J
Clin Drug Investig; 2022 Nov; 42(11):1009-1016. PubMed ID: 36239914
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and Safety of Posaconazole Administered by Intravenous Solution and Oral Tablet in Healthy Chinese Subjects and Effect of Food on Tablet Bioavailability.
Li H; Wei Y; Zhang S; Xu L; Jiang J; Qiu Y; Mangin E; Zhao XM; Xie S
Clin Drug Investig; 2019 Nov; 39(11):1109-1116. PubMed ID: 31432392
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of fluzoparib tablet formulation, an oral PARP inhibitor: effect of food on the pharmacokinetics and metabolism after oral dosing in healthy Chinese volunteers.
Wu M; Li X; Sun J; Chen H; Ding Y
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):503-508. PubMed ID: 33535835
[TBL] [Abstract][Full Text] [Related]
6. Food Effect on the Pharmacokinetics of VC004, a Tropomyosin Receptor Kinase Inhibitor: A Randomized Crossover Trial in Healthy Chinese Subjects.
Hu L; Sun Q; Tang L; Cai M; Qian W; Dou T; Wang H; Wu Y; Liu Y
Clin Drug Investig; 2024 Jan; 44(1):79-85. PubMed ID: 38112942
[TBL] [Abstract][Full Text] [Related]
7. Effect of food on the pharmacokinetics of clozapine orally disintegrating tablet 12.5 mg: a randomized, open-label, crossover study in healthy male subjects.
Disanto AR; Golden G
Clin Drug Investig; 2009; 29(8):539-49. PubMed ID: 19591515
[TBL] [Abstract][Full Text] [Related]
8. Effects of meal type on the bioavailability of vutiglabridin, a novel anti-obesity agent, in healthy subjects.
Won H; Yoon DY; Lee S; Cho JY; Oh J; Jang IJ; Yoo SK; Yu KS
Clin Transl Sci; 2024 Mar; 17(3):e13744. PubMed ID: 38436494
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
11. Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males.
Li J; Tan Y; Li K; Hui AM; Wu Z; Han P; Wei Z; Qiu J; Diao L; Wang X
Adv Ther; 2023 Mar; 40(3):1074-1086. PubMed ID: 36627544
[TBL] [Abstract][Full Text] [Related]
12. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and tolerability of eletriptan hydrobromide in healthy Korean subjects.
Kim YK; Shin KH; Alderman J; Yu KS; Jang IJ; Lee S
Drug Des Devel Ther; 2018; 12():331-337. PubMed ID: 29497279
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic comparison of sustained- and immediate-release oral formulations of cilostazol in healthy Korean subjects: a randomized, open-label, 3-part, sequential, 2-period, crossover, single-dose, food-effect, and multiple-dose study.
Lee D; Lim LA; Jang SB; Lee YJ; Chung JY; Choi JR; Kim K; Park JW; Yoon H; Lee J; Park MS; Park K
Clin Ther; 2011 Dec; 33(12):2038-53. PubMed ID: 22129569
[TBL] [Abstract][Full Text] [Related]
15. A randomized phase I study to evaluate the safety, tolerability, pharmacokinetics and food-effect of Iguratimod in healthy adult volunteers.
Xiao F; Zhang F; Zhang LL; Wei W
Eur J Clin Pharmacol; 2018 Jan; 74(1):69-77. PubMed ID: 29051989
[TBL] [Abstract][Full Text] [Related]
16. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
17. Effect of High-Fat Food on the Pharmacokinetic Profile and Safety of SAF-189s, an ALK/ROS1 Inhibitor, in Healthy Chinese Adults.
Qin H; Tan Y; Diao L; Hui AM; Wu Z; Zhou Y; Sun J; Xiang X; Qiu J; Hu W
Drugs R D; 2023 Dec; 23(4):465-473. PubMed ID: 37934354
[TBL] [Abstract][Full Text] [Related]
18. Effects of Food on the Pharmacokinetic Properties and Mass Balance of Henagliflozin in Healthy Male Volunteers.
Chen ZD; Chen Q; Zhu YT; Zhang YF; Zhan Y; Chen XF; Liang X; Jia JY; Yu C; Liu HY; Zou JJ; Liu YM; Zhong DF
Clin Ther; 2021 Sep; 43(9):e264-e273. PubMed ID: 34366153
[TBL] [Abstract][Full Text] [Related]
19. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
20. Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects.
Kim E; Kim A; Yi S; Kim YK; Jang SB; Byun HM; Yoon SH; Cho JY; Jang IJ; Yu KS; Lee S
Eur J Clin Pharmacol; 2018 Oct; 74(10):1261-1272. PubMed ID: 29907887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]